drugset / Trial / NCT02935530

Thromboprophylaxis After Surgery for Gynecologic Malignancy in China

NCT02935530

Phase 3 Completed 315 enrolled Huazhong University of Science and Technology
RandomizedParallel-groupOpen-labelTreatment

Summary

Venous thromboembolism (VTE) is an important cause of post-operative morbidity and mortality in women undergoing surgery for gynecologic malignancies. Although the benefit of thromboprophylaxis in reduction of post-operative VTE events after surgery for gynecologic cancers has been well documented around the world, the evidence for Chinese women is rare. The investigators designed this prospective and randomized study to assess the benefit of pharmacologic prophylaxis for patients received surgical treatment for gynecologic malignancies in China.

Timeline

Start
2016-01
Primary completion
2017-08
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Argatroban Small molecule 20 mg Other